Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Failla

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
La Clinica Terapeutica|May 9, 2008
[Heparin-binding epidermal growth factor (HB-EGF): myth or reality?]R Scuderi, A Failla
Military Medicine|January 1, 1972
Acrylic implants for frontal bone defectsI M Blatt, A Failla
Minerva Cardioangiologica|February 18, 1999
[Combination treatment of lymphedema. Our experience]S Michelini, C Campisi, A Failla, et al.
Minerva Cardioangiologica|February 18, 1999
[Study on the efficacy of ginkgo biloba extract, magnesium and levo-arginine in the treatment of patients with 2d stage arteriopathies. A preliminary study]S Michelini, A Micci, A Failla, et al.
Minerva Cardioangiologica|January 1, 1996
[Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)]S Michelini, A Micci, A Failla, et al.
Minerva Cardioangiologica|February 18, 1999
[National epidemiologic study of lymphedema]S Michelini, C Campisi, A Cavezzi, et al.
Minerva Medica|February 9, 2013
Paracrine activity of heparin-binding EGF-like growth factor in atherogenesis: an immunohistochemical studyP Castrogiovanni, R Scuderi, S Travali, et al.
La Clinica Terapeutica|February 13, 2008
[Central diabetes insipidus as a first manifestation of lung adenocarcinoma]A Granata, M Figura, S Gulisano, et al.
La Clinica Terapeutica|January 23, 2016
[Phosphorus: a new cardiovascular risk factor?]M Insalaco, R Scuderi, L Zanoli, et al.
La Clinica Terapeutica|March 4, 2010
[Immunolocalization of HB-EGF in human atherosclerotic plaques]R Scuderi, S Travali, P Castrogiovanni, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
La Clinica Terapeutica|May 9, 2008
[Heparin-binding epidermal growth factor (HB-EGF): myth or reality?]R Scuderi, A Failla
Military Medicine|January 1, 1972
Acrylic implants for frontal bone defectsI M Blatt, A Failla
Minerva Cardioangiologica|February 18, 1999
[Combination treatment of lymphedema. Our experience]S Michelini, C Campisi, A Failla, et al.
Minerva Cardioangiologica|February 18, 1999
[Study on the efficacy of ginkgo biloba extract, magnesium and levo-arginine in the treatment of patients with 2d stage arteriopathies. A preliminary study]S Michelini, A Micci, A Failla, et al.
Minerva Cardioangiologica|January 1, 1996
[Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)]S Michelini, A Micci, A Failla, et al.
Minerva Cardioangiologica|February 18, 1999
[National epidemiologic study of lymphedema]S Michelini, C Campisi, A Cavezzi, et al.
Minerva Medica|February 9, 2013
Paracrine activity of heparin-binding EGF-like growth factor in atherogenesis: an immunohistochemical studyP Castrogiovanni, R Scuderi, S Travali, et al.
La Clinica Terapeutica|February 13, 2008
[Central diabetes insipidus as a first manifestation of lung adenocarcinoma]A Granata, M Figura, S Gulisano, et al.
La Clinica Terapeutica|January 23, 2016
[Phosphorus: a new cardiovascular risk factor?]M Insalaco, R Scuderi, L Zanoli, et al.
La Clinica Terapeutica|March 4, 2010
[Immunolocalization of HB-EGF in human atherosclerotic plaques]R Scuderi, S Travali, P Castrogiovanni, et al.
Pageof 2